InterVenn Biosciences, a precision diagnostics company advancing liquid biopsy with glycoproteomics, and Aranscia, a global provider of award-winning clinical workflow and diagnostic technology ...

At 22, Zoe Chung discovered she carried a gene mutation linked to breast and ovarian cancer. Six years later, a routine scan ...

The American Society for Reproductive Medicine published a report that concludes preimplantation genetic testing for ...

SmartRecruiters, the recruiting AI company and an SAP company, today announced "The Orchestrator" as its Job Title of the Year, following analysis of hiring data from thousands of companies worldwide ...

Aranscia will provide software solutions to facilitate the delivery of results from InterVenn's flagship glycoproteomic liquid biopsy test.

While the Pap was invented in the 1940s and involves inspecting cervical cells for precancerous or cancerous shifts, in the ...

Ovarian cancer often goes undetected for a long time. In seven out of 10 patients, the tumor has already formed secondary ...

NICE has proposed age-based CA125 thresholds to improve early ovarian cancer detection while reducing unnecessary scans in ...

University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for ...

Small intestine cancer occurs when abnormal cells grow in the tissues of the small bowel, the long tube that connects your ...

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...